CS MEDICA | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
CS MEDICA

BRIEF

published on 11/04/2024 at 09:06, 17 days 1 hour ago

CS MEDICA A/S Positioned for Strong Growth in Alternative Medicine Market

Market Growth Alternative Medicine CS MEDICA CANNASEN® CBD-infused Devices
PRESS RELEASE

published on 11/04/2024 at 09:01, 17 days 1 hour ago

Original-Research: CS MEDICA A/S (von NuWays AG): Buy
CS MEDICA A/S, a Danish Med-Tech company, revolutionizes alternative medicine with CBD-infused medical devices for autoimmune and stress-related conditions. Positioned for strong top-line growth

Alternative Medicine CS MEDICA A/S CBD-infused Medical Devices Top-line Growth Danish Med-Tech Company
BRIEF

published on 07/01/2024 at 12:07, 4 months 19 days ago

CS MEDICA Stock Now Also Traded on XETRA

Liquidity Trading XETRA CS MEDICA A/S Hauck Aufhäuser Lampe
PRESS RELEASE

published on 07/01/2024 at 12:02, 4 months 19 days ago

CS MEDICA Stock Now Also Traded on XETRA
CS MEDICA A/S shares now available for trading on XETRA, offering increased liquidity and trading opportunities. Private bank ensures liquidity provision as Designated Sponsor

Liquidity Trading XETRA CS MEDICA A/S Designated Sponsor
BRIEF

published on 06/17/2024 at 15:40, 5 months 3 days ago

CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel

Regulatory Approval CS MEDICA CBD-infused Medical Devices Israel CANNASEN®
PRESS RELEASE

published on 06/17/2024 at 15:35, 5 months 3 days ago

EQS-Adhoc: CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel
CS MEDICA Group achieves complete registration of CANNASEN® CBD-infused medical devices in Israel, marking a significant milestone in expanding its global footprint and offering innovation in substance-based medical devices containing bioactive CBD

Regulatory Approval CBD-infused Medical Devices Israel CANNASEN® CS MEDICA Group
BRIEF

published on 06/10/2024 at 14:11, 5 months 10 days ago

CS MEDICA A/S Plans Spin-Off and Listing of CANNORDIC A/S

IPO Spin-off CS MEDICA CANNORDIC CBD
PRESS RELEASE

published on 06/10/2024 at 14:06, 5 months 10 days ago

EQS-Adhoc: CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S
CS MEDICA A/S plans to spin off and list CANNORDIC A/S on the German Stock Market, targeting a preliminary valuation of MDKK 224. The strategic move aims to enhance market positioning and secure growth capital

IPO MedTech Spin-off CS MEDICA A/S CANNORDIC A/S

Accesswire

Published on 11/21/2024 at 10:03, 39 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 42 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 42 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 7 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 17 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 12 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 37 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 40 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 42 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 42 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 44 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 22 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE